Valeant Pharmaceuticals International (NYSE:VRX)
| CAPS Rating |
|
|---|---|
| Open | $0.00 |
| Previous Close | $47.98 |
| Daily Range | $47.19 - $48.10 |
| 52-Week Range | $32.05 - $57.24 |
| Market Cap | $14.13B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | 0.38 (1.40%) |
| Volume | 1,435,389 |
| Average Daily Volume | 0 |
VRX
VS S&P 500 (SPY)
VRX News and Commentary
- UPDATE: Valeant Pharma Withdraws Bid For ISTA Pharma – SmartMoney
- Valeant Pharma Withdraws Bid For Drug-Maker ISTA Pharma – SmartMoney
- Profiting From Stock Buybacks – SmartMoney
- The Stock Making Buffett’s Pals at the Sequoia Fund Rich: Valeant Pharmaceuticals – YCharts
- Buffett’s Pals at Sequoia Fund Own Less Berkshire, But Find Plenty of Winning Stocks – YCharts
- Valeant Pharma Sees 2012 Earnings Above Street Estimates – SmartMoney
- 3 Stocks Shaking the Market – The Motley Fool
- 5 of Last Week's Biggest Winners – The Motley Fool
- Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals – SmartMoney
How do you think VRX will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
182
Outperform
24
Underperform
All-Star Players
65
Outperform
5
Underperform
Wall Street
13
Outperform
4
Underperform
RSS Headlines
Fool UK
